title: Castleman's disease.
abstract: Castleman's disease (CD) is a rare atypical lymphoproliferative disorder whose morphology, soon after the original presentation of Castleman et al., has been definitely subdivided in a hyaline vascular (HV) and plasma cell (PC) histopathological pattern, with intermediate variants. The former occurs much more frequently than the latter and is usually localized to the mediastinum or pulmonary hilum. The latter involves lymph nodes separately or in aggregations and often displays multicentricity with systemic symptoms including autoimmune phenomena and aggressive course. Infections are the most frequent causes of patient demise in these cases, followed by malignancies such as Kaposi's sarcoma, malignant lymphoma or epithelial neoplasia. Increase of follicular dendritic reticulum cells (FDRC), often dysplastic, in the germinal center (GC) and marginal zone (MZ), broad MZ expansion with prominence of immunophenotypically aberrant B cells (Ki B3-negative, CD5-positive), possible predominance of paracortical plasma cells often with clusters of clonal l-light chain restricted plasma cells, increase of paracortical plasmacytoid monocytes, represent common hallmarks of CD. However, small hyalinized and hypervascular GCs with hypervascular interfollicular stroma and sinus effacement are common features of the HV variant, whereas hyperplastic GCs with plasma cell aggregates in lymph node paracortex and partially spared sinuses are characteristic features of the PC variant. The frequent concomitance of the HV and PC types at separate sites, together with transient morphological patterns from one type to the other and from the localized to multicentric form during the course of the disease, along with B and T cell impaired functions, with frequent development of autoantibodies, have suggested that CD is a single disorder related to immune dysregulation. A key event in the pathogenesis of CD has been recently suggested to be an abnormal production of a B cell growth factor, such as IL-6, leading to lymphoproliferation and plasma cell differentiation and being involved in the oncogenesis of plasmacytoma. In this event, Kaposi's sarcoma associated virus (HHV-8), which has been found in many cases of CD, especially in the multicentric form, could play a crucial role both in producing IL-6 and releasing angiogenic factors. A possible differentiation block may lead to the development of a malignant lymphoma. Kaposi's sarcoma or other malignant neoplasias can be supposed to be consequences of the immunodeficiency typical of CD.
authors.affiliation: Departement of Biomedical Science and Human Oncology, University of Torino, Torino, I-10126, Italy. palestro@molinette.unito.it
authors.forename: G
authors.initials: G
authors.lastname: Palestro
authors.forename: F
authors.initials: F
authors.lastname: Turrini
authors.forename: M
authors.initials: M
authors.lastname: Pagano
authors.forename: L
authors.initials: L
authors.lastname: Chiusa
mesh_terms: D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology; D005871:Castleman Disease / Q000145:classification / Q000378:metabolism / Q000473:pathology / Q000821:virology; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D006818:Hyalin / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008198:Lymph Nodes / Q000098:blood supply / Q000473:pathology; D008477:Mediastinal Diseases / Q000209:etiology / Q000473:pathology; D010950:Plasma Cells / Q000473:pathology
chemical_list: D015850:Interleukin-6